Eduardo A. Vega

1.5k total citations
87 papers, 931 citations indexed

About

Eduardo A. Vega is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eduardo A. Vega has authored 87 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Surgery, 44 papers in Oncology and 35 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eduardo A. Vega's work include Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Pancreatic and Hepatic Oncology Research (23 papers) and Hepatocellular Carcinoma Treatment and Prognosis (21 papers). Eduardo A. Vega is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Pancreatic and Hepatic Oncology Research (23 papers) and Hepatocellular Carcinoma Treatment and Prognosis (21 papers). Eduardo A. Vega collaborates with scholars based in United States, Argentina and Chile. Eduardo A. Vega's co-authors include C. Mautalén, Claudius Conrad, Jean‐Nicolas Vauthey, Pablo Ingelmo, Catherine E. Ferland, Katharina Joechle, H.E. Scaglia, Ching‐Wei D. Tzeng, Jeffrey E. Lee and Onur Kutlu and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Bone and Mineral Research.

In The Last Decade

Eduardo A. Vega

79 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo A. Vega United States 18 416 410 286 214 133 87 931
Beomseok Suh South Korea 18 120 0.3× 253 0.6× 171 0.6× 26 0.1× 95 0.7× 40 785
Patricia O'Gorman United Kingdom 12 260 0.6× 533 1.3× 180 0.6× 21 0.1× 64 0.5× 15 1.0k
Stefano Bona Italy 22 1.4k 3.3× 495 1.2× 405 1.4× 22 0.1× 394 3.0× 54 1.7k
Aleksandra Kukla United States 20 401 1.0× 176 0.4× 273 1.0× 18 0.1× 54 0.4× 64 1.2k
Steven P. Feitelberg United States 10 259 0.6× 89 0.2× 57 0.2× 60 0.3× 75 0.6× 11 579
Miranda J.M. Dirx Netherlands 14 188 0.5× 454 1.1× 423 1.5× 29 0.1× 17 0.1× 18 1.0k
Rıfat Emral Türkiye 19 343 0.8× 92 0.2× 46 0.2× 35 0.2× 33 0.2× 65 1.1k
K. Wakai Japan 14 328 0.8× 388 0.9× 173 0.6× 12 0.1× 20 0.2× 18 988
Ogo Egbuna United States 18 230 0.6× 371 0.9× 127 0.4× 322 1.5× 10 0.1× 37 1.3k

Countries citing papers authored by Eduardo A. Vega

Since Specialization
Citations

This map shows the geographic impact of Eduardo A. Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo A. Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo A. Vega more than expected).

Fields of papers citing papers by Eduardo A. Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo A. Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo A. Vega. The network helps show where Eduardo A. Vega may publish in the future.

Co-authorship network of co-authors of Eduardo A. Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo A. Vega. A scholar is included among the top collaborators of Eduardo A. Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo A. Vega. Eduardo A. Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vega, Eduardo A., et al.. (2024). The impact of the COVID-19 pandemic on patients with pancreatic cancer. Journal of Gastrointestinal Surgery. 28(6). 830–835. 4 indexed citations
2.
3.
Vega, Eduardo A., Christopher S. Lathan, George P. Sorescu, et al.. (2024). Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?. Journal of Gastrointestinal Surgery. 28(9). 1392–1399.
4.
Vega, Eduardo A., et al.. (2024). Solid Pseudopapillary Tumor of the Pancreas: Is Enucleation Safe?. Annals of Surgical Oncology. 31(6). 4105–4111. 4 indexed citations
5.
Panettieri, Elena, et al.. (2024). Global practice patterns of preoperative image reconstruction for liver surgery. Journal of Gastrointestinal Surgery. 28(1). 26–32. 2 indexed citations
6.
Altermatt, Fernando, et al.. (2024). Opioid use in Latin America: Chronicle of a death foretold?. Journal of Global Health. 14. 3040–3040.
7.
Vega, Eduardo A., Onur Kutlu, Olga Kozyreva, et al.. (2023). R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Surgical Oncology. 49. 101961–101961. 3 indexed citations
8.
Vega, Eduardo A., et al.. (2023). Analysis of the Extent of Liver Oncological Extended Resection for Incidental Gallbladder Cancer: How Much Is Too Much?. Annals of Surgical Oncology. 30(11). 6594–6600. 3 indexed citations
9.
Vega, Eduardo A., et al.. (2023). Subsegmental approaches to S7: anatomic laparoscopic transdiaphragmatic and nonanatomic robotic transthoracic. Surgical Endoscopy. 37(10). 8154–8155. 1 indexed citations
10.
Mohamed, Ahmed S., et al.. (2021). Colchicine-induced rhabdomyolysis: a review of 83 cases. BMJ Case Reports. 14(7). e241977–e241977. 1 indexed citations
11.
Vega, Eduardo A., Onur Kutlu, Sylvia V. Alarcon, et al.. (2021). The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Surgical Oncology. 40. 101694–101694. 2 indexed citations
12.
Panettieri, Elena, Harufumi Maki, Bradford J. Kim, et al.. (2021). Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma. Surgical Oncology. 40. 101696–101696. 4 indexed citations
13.
Kutlu, Onur, Eduardo A. Vega, Christopher S. Lathan, et al.. (2020). Laparoscopic pancreatectomy for cancer in high volume centers is associated with an increased use and fewer delays of adjuvant chemotherapy. HPB. 23(4). 625–632. 14 indexed citations
14.
Joechle, Katharina, Timothy J. Vreeland, Eduardo A. Vega, et al.. (2020). Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. Journal of Gastrointestinal Surgery. 24(5). 1033–1039. 15 indexed citations
15.
Joechle, Katharina, Claire Goumard, Eduardo A. Vega, et al.. (2018). Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB. 21(3). 361–369. 9 indexed citations
16.
Okuno, Masayuki, Claire Goumard, Scott Kopetz, et al.. (2018). RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Annals of Surgical Oncology. 25(8). 2457–2466. 23 indexed citations
17.
18.
Viñuela, Eduardo, Eduardo A. Vega, Suguru Yamashita, et al.. (2017). Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries. Annals of Surgical Oncology. 24(8). 2334–2343. 26 indexed citations
19.
Bagur, A., et al.. (1996). Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women.. PubMed. 56(3). 247–51. 7 indexed citations
20.
Mautalén, C., et al.. (1990). [Bone mineral density of the lumbar spine and proximal femur of normal females in Buenos Aires].. PubMed. 50(1). 25–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beomseok Suh Breakdown of academic impact, for papers by Patricia O'Gorman Breakdown of academic impact, for papers by Stefano Bona Breakdown of academic impact, for papers by Aleksandra Kukla Breakdown of academic impact, for papers by Steven P. Feitelberg Breakdown of academic impact, for papers by Miranda J.M. Dirx Breakdown of academic impact, for papers by Rıfat Emral Breakdown of academic impact, for papers by K. Wakai Breakdown of academic impact, for papers by Ogo Egbuna
Rankless by CCL
2026